Literature DB >> 26837582

2015 FDA drug approvals.

Asher Mullard.   

Abstract

Mesh：

Year:  2016        PMID： 26837582     DOI： 10.1038/nrd.2016.15

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  2014 FDA drug approvals.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694
  1 in total
  27 in total

Review 1.  What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?

Authors:  Antonia Busse; Diana Lüftner
Journal:  Breast Care (Basel)       Date:  2019-02-13       Impact factor: 2.860

Review 2.  The impact of structural biology in medicine illustrated with four case studies.

Authors:  Tiancen Hu; Elizabeth R Sprague; Michelle Fodor; Travis Stams; Kirk L Clark; Sandra W Cowan-Jacob
Journal:  J Mol Med (Berl)       Date:  2017-07-01       Impact factor: 4.599

Review 3.  Strategies and challenges for the next generation of antibody-drug conjugates.

Authors:  Alain Beck; Liliane Goetsch; Charles Dumontet; Nathalie Corvaïa
Journal:  Nat Rev Drug Discov       Date:  2017-03-17       Impact factor: 84.694

Review 4.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 5.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

Review 6.  Translating Knowledge Into Therapy for Acute Kidney Injury.

Authors:  Mark de Caestecker; Raymond Harris
Journal:  Semin Nephrol       Date:  2018-01       Impact factor: 5.299

Review 7.  Impact of the Protein Data Bank on antineoplastic approvals.

Authors:  John D Westbrook; Rose Soskind; Brian P Hudson; Stephen K Burley
Journal:  Drug Discov Today       Date:  2020-02-14       Impact factor: 7.851

8.  Accurate Sequence Analysis of a Monoclonal Antibody by Top-Down and Middle-Down Orbitrap Mass Spectrometry Applying Multiple Ion Activation Techniques.

Authors:  Luca Fornelli; Kristina Srzentić; Romain Huguet; Christopher Mullen; Seema Sharma; Vlad Zabrouskov; Ryan T Fellers; Kenneth R Durbin; Philip D Compton; Neil L Kelleher
Journal:  Anal Chem       Date:  2018-06-28       Impact factor: 6.986

Review 9.  How Structural Biologists and the Protein Data Bank Contributed to Recent FDA New Drug Approvals.

Authors:  John D Westbrook; Stephen K Burley
Journal:  Structure       Date:  2018-12-27       Impact factor: 5.006

10.  Design analysis indicates Potential overestimation of treatment effects in randomized controlled trials supporting Food and Drug Administration cancer drug approvals.

Authors:  Emily M Lord; Isabelle R Weir; Ludovic Trinquart
Journal:  J Clin Epidemiol       Date:  2018-07-02       Impact factor: 6.437
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.